Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola Landgren

Showing results (221-230 of 519) with videos related to

Pageof 52
Sort By:
Clinical Lymphoma & Myeloma|April 14, 2009
Genetics- and immune-related factors in the pathogenesis of lymphoplasmacytic lymphoma/ Waldenström's macroglobulinemiaSigurdur Y Kristinsson, Jill Koshiol, Lynn R Goldin, et al.
British Journal of Haematology|July 4, 2009
Common genetic variants in candidate genes and risk of familial lymphoid malignanciesXueying Sharon Liang, Neil Caporaso, Mary Lou McMaster, et al.
Blood|November 14, 2013
Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in SwedenIngemar Turesson, Stephanie A Kovalchik, Ruth M Pfeiffer, et al.
International Journal of Cancer|July 8, 2009
Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in SwedenSigurdur Y Kristinsson, Magnus Björkholm, Lynn R Goldin, et al.
Blood Reviews|August 11, 2020
Defining the undetectable: The current landscape of minimal residual disease assessment in multiple myeloma and goals for future clarityBenjamin T Diamond, Even Rustad, Kylee Maclachlan, et al.
The New England Journal of Medicine|February 14, 2009
B-cell clones as early markers for chronic lymphocytic leukemiaOla Landgren, Maher Albitar, Wanlong Ma, et al.
Annals of Internal Medicine|January 17, 2018
Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms: A Population-Based Cohort StudyMalin Hultcrantz, Magnus Björkholm, Paul W Dickman, et al.
Blood|June 6, 2015
Survival in patients with familial and sporadic myeloproliferative neoplasmsMalin Hultcrantz, Sigrún H Lund, Ola Landgren, et al.
JAMA|May 10, 2007
Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virusThomas P Giordano, Louise Henderson, Ola Landgren, et al.
Annals of Hematology|November 4, 2016
History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based studyEbba K Lindqvist, Ola Landgren, Sigrún H Lund, et al.
Pageof 52

Showing results (221-230 of 519) with videos related to

Sort By:
Pageof 52
Clinical Lymphoma & Myeloma|April 14, 2009
Genetics- and immune-related factors in the pathogenesis of lymphoplasmacytic lymphoma/ Waldenström's macroglobulinemiaSigurdur Y Kristinsson, Jill Koshiol, Lynn R Goldin, et al.
British Journal of Haematology|July 4, 2009
Common genetic variants in candidate genes and risk of familial lymphoid malignanciesXueying Sharon Liang, Neil Caporaso, Mary Lou McMaster, et al.
Blood|November 14, 2013
Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in SwedenIngemar Turesson, Stephanie A Kovalchik, Ruth M Pfeiffer, et al.
International Journal of Cancer|July 8, 2009
Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in SwedenSigurdur Y Kristinsson, Magnus Björkholm, Lynn R Goldin, et al.
Blood Reviews|August 11, 2020
Defining the undetectable: The current landscape of minimal residual disease assessment in multiple myeloma and goals for future clarityBenjamin T Diamond, Even Rustad, Kylee Maclachlan, et al.
The New England Journal of Medicine|February 14, 2009
B-cell clones as early markers for chronic lymphocytic leukemiaOla Landgren, Maher Albitar, Wanlong Ma, et al.
Annals of Internal Medicine|January 17, 2018
Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms: A Population-Based Cohort StudyMalin Hultcrantz, Magnus Björkholm, Paul W Dickman, et al.
Blood|June 6, 2015
Survival in patients with familial and sporadic myeloproliferative neoplasmsMalin Hultcrantz, Sigrún H Lund, Ola Landgren, et al.
JAMA|May 10, 2007
Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virusThomas P Giordano, Louise Henderson, Ola Landgren, et al.
Annals of Hematology|November 4, 2016
History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based studyEbba K Lindqvist, Ola Landgren, Sigrún H Lund, et al.
Pageof 52